Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation

by Karoline Koch, Julia Richter, Christoph Hanel, Andreas Huttmann, Ulrich Duhrsen, Wolfram Klapper
Published 2022-01-01

Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability

by Martina Broecker-Preuss, Nina Becher-Boveleth, Andreas Bockisch, Ulrich Dührsen, Stefan Müller
Published 2017-07-01

Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma

by Ulrich Dührsen, Mareike Tometten, Frank Kroschinsky, Arnold Ganser, Stefan Ibach, Stefanie Bertram, Andreas Hüttmann
Published 2021-05-01

CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo.

by Maria Dampmann, André Görgens, Michael Möllmann, Florian Murke, Ulrich Dührsen, Bernd Giebel, Jan Dürig
Published 2020-01-01

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab.

by Ferras Alashkar, Scott Rottinghaus, Colin Vance, Dörte Herich-Terhürne, Ulrich Dührsen, Roland Assert, Alexander Röth
Published 2020-01-01

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma

by Lars Kurch, Ulrich Dührsen, Andreas Hüttmann, Thomas W. Georgi, Osama Sabri, Regine Kluge, Dirk Hasenclever
Published 2021-09-01

Impairment of vocational activities and financial problems are frequent among German blood cancer survivors

by Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W. Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Published 2023-12-01

Patterns of follow‐up care in adult blood cancer survivors—Prospective evaluation of health‐related outcomes, resource use, and quality of life

by Hildegard Lax, Julia Baum, Nils Lehmann, Anja Merkel‐Jens, Dietrich W. Beelen, Karl‐Heinz Jöckel, Ulrich Dührsen
Published 2024-04-01

Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation

by Ferras Alashkar, Fuat H. Saner, Colin Vance, Ute Schmücker, Dörte Herich-Terhürne, Ulrich Dührsen, Angela Köninger, Alexander Röth
Published 2020-09-01

Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma

by Bettina Wagner, Ulrich Dührsen, Andreas Hüttmann, Holger Nückel, Rafael Tomoya Michita, Hana Rohn, Sabine Schramm, Peter A. Horn, Vera Rebmann
Published 2020-11-01

Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis

by Meike Farber, Yiyang Chen, Lucas Arnold, Michael Möllmann, Eva Boog-Whiteside, Yu-An Lin, H. Christian Reinhardt, Ulrich Dührsen, Maher Hanoun
Published 2021-11-01

Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study

by Nicola Hornung, Mirjam Frank, Nico Dragano, Jan Dürig, Ulrich Dührsen, Susanne Moebus, Raimund Erbel, Andreas Stang, Karl-Heinz Jöckel, Börge Schmidt
Published 2021-09-01

Rituximab maintenance therapy of follicular lymphoma in clinical practice

by Ulrich Dührsen, Stefanie Broszeit‐Luft, Annette Dieing, Andreas Lück, Piotr Porowski, Marcel Reiser, Ulrike Schwinger, Sandra Klawitter, Katja Krumm, Kathleen Jentsch‐Ullrich
Published 2018-07-01

Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.

by Maher Hanoun, Lewin Eisele, Masako Suzuki, John M Greally, Andreas Hüttmann, Semra Aydin, René Scholtysik, Ludger Klein-Hitpass, Ulrich Dührsen, Jan Dürig
Published 2012-01-01

A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort

by Lisa Baak, Mirjam Frank, Jan Dürig, Ulrich Dührsen, Per Hoffmann, Markus M. Nöthen, Nico Dragano, Raimund Erbel, Karl-Heinz Jöckel, Börge Schmidt
Published 2022-03-01

Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia

by Patricia Johansson, Laura Dierichs, Ludger Klein-Hitpass, Anke K. Bergmann, Michael Möllmann, Sascha Menninger, Peter Habenberger, Bert Klebl, Jens T. Siveke, Ulrich Dührsen, Axel Choidas, Jan Dürig
Published 2020-10-01

Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing

by Patricia Johansson, Ludger Klein-Hitpass, Bettina Budeus, Matthias Kuhn, Chris Lauber, Michael Seifert, Ingo Roeder, Roman Pförtner, Martin Stuschke, Ulrich Dührsen, Anja Eckstein, Jan Dürig, Ralf Küppers
Published 2020-04-01

Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner

by Yahya S. Al-Matary, Lacramioara Botezatu, Bertram Opalka, Judith M. Hönes, Robert F. Lams, Aniththa Thivakaran, Judith Schütte, Renata Köster, Klaus Lennartz, Thomas Schroeder, Rainer Haas, Ulrich Dührsen, Cyrus Khandanpour
Published 2016-10-01

Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.

by Maria Göbel, Lewin Eisele, Michael Möllmann, Andreas Hüttmann, Patricia Johansson, René Scholtysik, Manuela Bergmann, Raymonde Busch, Hartmut Döhner, Michael Hallek, Till Seiler, Stephan Stilgenbauer, Ludger Klein-Hitpass, Ulrich Dührsen, Jan Dürig
Published 2013-01-01

Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival

by Sara Oubari, Ute Hegenbart, Renate Schoder, Maximilian Steinhardt, Maria Papathanasiou, Tienush Rassaf, Andreas Thimm, Tim Hagenacker, Eyad Naser, Ulrich Duhrsen, Hans C. Reinhardt, Martin Kortum, Hermine Agis, Stefan Schonland, Alexander Carpinteiro
Published 2023-07-01